Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...
Reexamination Certificate
2006-11-21
2010-02-16
Powers, Fiona T (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Acyclic nitrogen double bonded to acyclic nitrogen, acyclic...
C514S381000, C514S404000, C534S775000, C534S792000, C548S253000, C548S367400
Reexamination Certificate
active
07662804
ABSTRACT:
Disclosed herein are novel diazenyl pyrazole compounds and related compounds. Also disclosed herein are methods of using these compounds for the treatment of diseases and conditions associated with modulating a thrombopoietin activity.
REFERENCES:
patent: 1792355 (1931-02-01), Boeniger
patent: 3150151 (1964-09-01), Urbschaft et al.
patent: 3208991 (1965-09-01), Blout et al.
patent: 3718678 (1973-02-01), Farrand et al.
patent: 3754857 (1973-08-01), McKay
patent: 3966900 (1976-06-01), Hennart et al.
patent: 4322533 (1982-03-01), Lesher et al.
patent: 4451398 (1984-05-01), Patsch et al.
patent: 4720304 (1988-01-01), Ruff et al.
patent: 5001229 (1991-03-01), Franke et al.
patent: 5051417 (1991-09-01), Nadler et al.
patent: 5155015 (1992-10-01), Jimbo
patent: 5164404 (1992-11-01), Dahl et al.
patent: 5298658 (1994-03-01), Fabricius
patent: 5482546 (1996-01-01), Eida
patent: 5766581 (1998-06-01), Bartley et al.
patent: 6075044 (2000-06-01), Wang et al.
patent: 6448238 (2002-09-01), Shoichet et al.
patent: 6552008 (2003-04-01), Duffy et al.
patent: 6642265 (2003-11-01), Luengo et al.
patent: 6649631 (2003-11-01), Orme et al.
patent: 6670387 (2003-12-01), Luengo et al.
patent: 6720345 (2004-04-01), Luengo et al.
patent: 6875786 (2005-04-01), Duffy et al.
patent: 6916798 (2005-07-01), Green et al.
patent: 6964701 (2005-11-01), Foster et al.
patent: 6964977 (2005-11-01), Harris et al.
patent: 7026334 (2006-04-01), Takemoto et al.
patent: 7071217 (2006-07-01), Dickerson et al.
patent: 7105529 (2006-09-01), Davis et al.
patent: 7129253 (2006-10-01), Glennon et al.
patent: 7135550 (2006-11-01), Come
patent: 7160870 (2007-01-01), Duffy et al.
patent: 7335649 (2008-02-01), Duffy et al.
patent: 7414040 (2008-08-01), Heerding
patent: 2003/0229453 (2003-12-01), Antonysamy et al.
patent: 2004/0019190 (2004-01-01), Erickson-Miller et al.
patent: 2004/0053299 (2004-03-01), Delorme et al.
patent: 2004/0058990 (2004-03-01), Duffy et al.
patent: 2004/0082626 (2004-04-01), Takemoto et al.
patent: 2004/0220146 (2004-11-01), Freeman et al.
patent: 2004/0253178 (2004-12-01), Atwell et al.
patent: 2005/0049267 (2005-03-01), Suto et al.
patent: 2005/0153977 (2005-07-01), Sugasawa et al.
patent: 2005/0234020 (2005-10-01), Heerding
patent: 2006/0069140 (2006-03-01), Miyaji et al.
patent: 2006/0084682 (2006-04-01), Heerding et al.
patent: 2006/0094694 (2006-05-01), Owada et al.
patent: 2006/0116417 (2006-06-01), Chen et al.
patent: 2006/0178518 (2006-08-01), Moore
patent: 2007/0105824 (2007-05-01), Erickson-Miller et al.
patent: 653800 (1965-03-01), None
patent: 193633 (1907-02-01), None
patent: 450819 (1927-10-01), None
patent: 4335623 (1995-04-01), None
patent: 0141067 (1984-08-01), None
patent: 0335237 (1989-03-01), None
patent: 1080864 (1967-08-01), None
patent: 2 168 347 (1986-06-01), None
patent: 2-287457 (1990-11-01), None
patent: 2000-206645 (2000-07-01), None
patent: 2001-152055 (2001-05-01), None
patent: 2002-020641 (2002-01-01), None
patent: 2002-129072 (2002-05-01), None
patent: 2002-129073 (2002-05-01), None
patent: 2003-128946 (2003-05-01), None
patent: 2003-313450 (2003-11-01), None
patent: 2003-335972 (2003-11-01), None
patent: 2004-143118 (2004-05-01), None
patent: WO 01/17349 (2001-03-01), None
patent: WO 01/21180 (2001-03-01), None
patent: WO 01/89457 (2001-11-01), None
patent: WO 03/011287 (2003-02-01), None
patent: WO 03/037905 (2003-05-01), None
patent: WO 03/082265 (2003-09-01), None
patent: WO 03/098992 (2003-12-01), None
patent: WO 03/103686 (2003-12-01), None
patent: WO 2005/097119 (2005-10-01), None
patent: WO 2005/107466 (2005-11-01), None
patent: WO 2005/118551 (2005-12-01), None
patent: WO 2006/004545 (2006-01-01), None
patent: WO 2006/052936 (2006-05-01), None
patent: WO 2006/076442 (2006-07-01), None
patent: PCT/US2007/006547 (2007-03-01), None
patent: WO 2007/062078 (2007-05-01), None
Lipinski, “Bioisosteres in Drug Design”, Annual Reports in Medicinal Chemistry, 21, 283-291, 1986.
Snavely et al., Chemical Abstraccts, 58:6914, 1963 (Registry No. 98439-02-2).
Snavely et al., Inorganic Chemistry, 1(4), 890-892, 1963.
Abdel-Latif et al., “Reaction of Diazocompounds and Hydrazines on Indolin-2-one Derivatives”,Indian J. Chem., 1985, 24B(7), 775-777.
Abdel-Rahman et al., “Synthesis of some 1,2,4-Triazino [4,3-a] indole derivatives”,J. Indian Chem. Soc., 1991, 68(11), 621-624.
Abdel-Rahman et al., “Synthesis of Some New 2,3/2,4-Disubstituted-1,2,4-Trianzino [5,6-b] Indoles”,Asian J. Chem., 1992, 4(2), 364-371.
Alam et al., “Analytical studies of biologically active compounds-I: Quantitative Determination of Metabolies of 3-Substituted Isatin Derivatives by TLC”,Proc. Pakistan Acad. Sci., 1992, 29(2), 113-120.
Alam et al., “Biopharmaceutical Studies of 3-Substituted Isatin Derivatives”,Indian J. Exp. Biol., 1990, 28(10), 940-942.
Alam et al.,“Electronic Spectra of Isatin Derivatives”,Proc. Pakistan Acad. Sci., 1987, 24(4), 337-348.
Ali, et al., “Analytical Studies on Biologically Active Compounds.Part II. Separation and Quantitation of Mixtures of Isatin Derivatives for Application to Metabolism Studies”,Pak. J. Sci. Ind. Res., 1995, 38(8), 330-332.
Aly, et al., “Reaction of 1-Acetyl-3-dicyanomethylene-1,3-dihydro-2H-indo1-2-one with Some Nucleophilic Reagents: Synthesis of Some Indole and Quinoline Derivatives”,Heterocyclic Comm., 2000, 6(3), 249-252.
Aly, et al., “Synthesis and reactions of 1,3-dihydro-3-(3',5'-dioxo-2'H-1'-phenylpyrazolidene) -2h-indol-2-one”,Bull. Fac. Sci., Assuit Univ., 1996, 25(1-B), 25-33.
Amin, “Spectrophotometric Method for the Determination of Titanium in Soil, Geo—Chemical, Silicates Rock and Paint Samples”,Quim. Anal., 2002, 20, 217-222.
Amin, et al., “Simultaneous Spectrophotometric Determination of Thorium and Rare Earth Metals with Pyrimidine Azo Dyes and Cetylpyridinium Chloride”,Talanta, 2001, 54(4), 611-620.
Atta et al., “β-Lactam Formation on Thin-Layer Chromatoplates”,Indian J. Chem, 1979, 18B(5), 475-476.
Back et al., “Zusammenhange zwischen Konstitution von neutralziehenden Metallkomplexfarbstoffen, Verteilungsgleichgewichten zwischen flussigen Phasen und Farbegleichgewichten auf Polyamiden”,Helv. Chim. Acta, 1959, 166, 1539-1553.
Bains et al. “Silicon chemistry as a novel source of chemical diversity in drug design.”Current Opinion in Drug Discovery and Development; 6(4):526-543 (2003).
Ballantine et al., “Rearrangement and Cyclization in the Mass Spectra of a Series of Isatin Carbonyl Derivatives of Medicinal Interest. 2-Oxo-3-Indolinylidene Anils (N-Arylketimines), 2-Oxo-3- Indolinylidene Phenylhydrazones, 2-Oxo-3, 3-Bis (O-Diaminoaryl) Indolyl Derivatives and Their 2,3- Quinoxaline Heterocyclic Analogues”,Organic Mass Spectrometry, 1971, 5(8), 1003-1014.
Bartley et al. “Identification and Cloning of a Megakaryocyte Growth and Development Factor That Is a Ligand for the Cytokine Receptor Mpl.”Cell; 77:1117-11124 (1994).
Baser et al., 1997,Blood, 89,3118-3128.
Bauer, “Oxalic Acid Quinochlorides (II)”,Berichte der Deutschen Chemischen Gesellschaft, 1909, 42, 2111-2118.
Bauer, “Uber Oxalsaure-imidchloride”,Berichte der Deutschen Chemischen Gesellschaft, 1907, 2650-2663.
Beaton, et al., “Preparation and Hydrogen Bonding Studies of Phenylhydrazone Derivatives Of Alloxan: Crystal And Molecular Structure of Pyrimidine-2(1H),4(3H),5,6-tetraone 5-(2-nitrophenyl) hydrazone”,J. Chem. Soc., Perkin Trans. II:, 1987, (4), 469-472.
Bogert et al., “Azo Derivatives of the Pyrimidines”,Proc. Natl. Acad. Sci., 1932, 18,215-222.
Bramson, et al., Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis,J. Med. Chem., 2001, 44(25), 4339-4358.
Braun et al., “Isatin-4-Carbonsäure”,Berichte der Deutschen Chemischen Gesellschaft, 1923, 2343-2347.
Buu-Hoi et al, &#x
Kallel E. Adam
Phillips Dean P.
Zhi Lin
Dustman Wayne J.
Gimmi Edward R.
Kinzig Charles M.
Powers Fiona T
SmithKline Beecham Corp.
LandOfFree
Thrombopoietin activity modulating compounds and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombopoietin activity modulating compounds and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombopoietin activity modulating compounds and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4179401